Dr. Mehta on the Current Treatment Paradigm in HER2-Positive Gastric Cancer

preview_player
Показать описание
Rutika J. Mehta, MD, MPH, a medical oncologist specializing in gastrointestinal cancer at Moffitt Cancer Center, discusses the current treatment paradigm in HER2-positive gastric cancer.
Рекомендации по теме